While Icon Plc has overperformed by 1.02%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ICLR fell by -27.49%, with highs and lows ranging from $347.72 to $125.10, whereas the simple moving average fell by -20.92% in the last 200 days.
On April 29, 2025, JP Morgan Downgraded Icon Plc (NASDAQ: ICLR) to Neutral. A report published by TD Cowen on April 14, 2025, Downgraded its rating to ‘Hold’ for ICLR. Barclays also Downgraded ICLR shares as ‘Equal Weight’, setting a target price of $165 on the company’s shares in a report dated April 10, 2025. Goldman March 21, 2025d the rating to Neutral on March 21, 2025, and set its price target from $250 to $200. RBC Capital Mkts initiated its ‘Outperform’ rating for ICLR, as published in its report on January 07, 2025. Robert W. Baird’s report from October 24, 2024 suggests a price prediction of $340 for ICLR shares, giving the stock a ‘Neutral’ rating. Redburn Atlantic also rated the stock as ‘Neutral’.
Analysis of Icon Plc (ICLR)
Further, the quarter-over-quarter decrease in sales is -4.26%, showing a negative trend in the upcoming months.
One of the most important indicators of Icon Plc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 8.01% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.27, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and ICLR is recording 1.53M average volume. On a monthly basis, the volatility of the stock is set at 3.45%, whereas on a weekly basis, it is put at 3.48%, with a gain of 0.83% over the past seven days. Furthermore, long-term investors anticipate a median target price of $175.47, showing growth from the present price of $152.07, which can serve as yet another indication of whether ICLR is worth investing in or should be passed over.
How Do You Analyze Icon Plc Shares?
The Diagnostics & Research market is dominated by Icon Plc (ICLR) based in the Ireland. When comparing Icon Plc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 16.55, there is a growth in quarterly earnings of -15.39%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.65%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 88.25% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ICLR shares are owned by institutional investors to the tune of 88.25% at present.
